Cocrystal Pharma to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

Rhea-AI Summary

Cocrystal Pharma (NASDAQ: COCP) will present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020, at 3:30 PM EDT, led by Chairman and CEO Dr. Gary Wilcox. The presentation will be followed by virtual one-on-one meetings with qualified investors. A live video webcast will be available on the Company's website.

– Live video webcast with Chairman and CEO, Dr. Gary Wilcox, on Monday, September 14^th at 3:30 PM EDT –

BOTHELL, WA, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that Dr. Gary Wilcox, Chairman and Chief Executive Officer of Cocrystal, will present at H.C. Wainwright 22^nd Annual Global Investment Conference on Monday, September 14, 2020 at 3:30 PM EDT.

In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information, please visit the conference website here.

A live video webcast of the presentation will be available on the IR Calendar page of the Investors section of the Company’s website (cocrystalpharma.com). The video webcast replay will be made available two hours following the event.

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, SARS-CoV-2 virus, hepatitis C viruses, and norovirus infections. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Investor and Media Contact:

JTC Team, LLC
(833) 475-8247
COCP@jtcir.com

###

FAQ

When is Cocrystal Pharma's presentation at the H.C. Wainwright conference?

Cocrystal Pharma's presentation is on September 14, 2020, at 3:30 PM EDT.

Who is presenting for Cocrystal Pharma at the conference?

Dr. Gary Wilcox, Chairman and CEO, will present for Cocrystal Pharma.

Will there be a live webcast of Cocrystal Pharma's presentation?

Yes, there will be a live video webcast available on Cocrystal Pharma's website.

Can investors have one-on-one meetings with Cocrystal Pharma's management?

Yes, management will participate in virtual one-on-one meetings with qualified investors registered for the conference.

What is the focus of Cocrystal Pharma's research?

Cocrystal Pharma focuses on developing novel antiviral therapeutics targeting various viruses, including influenza and SARS-CoV-2.